UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 8-K

                                CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported)    July 19, 2005

                          ON THE GO HEALTHCARE, INC.
            (Exact name of registrant as specified in its charter)

   DELAWARE                      333-61538                 98-0231687
- ---------------             --------------------    -------------------
(State or Other                 (Commission          (IRS Employer
Jurisdiction of                 File Number)           Identification
 Incorporation)                                                   No.)

                         85 Corstate Avenue, Unit #1
                              Concord, Ontario
                               Canada L4K 4Y2
              ---------------------------------------------------
              (Address of principal executive offices) (Zip Code)


     Registrant's telephone number, including area code:  (905) 760-2987

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))


ITEM 1.01  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
ITEM 2.01  COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.
ITEM 2.03  CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER
           AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.

On July 19, 2005, we entered into an agreement with to purchase all of the
issued and outstanding shares of Infinity Technologies Inc. stock in exchange
for $3,120,000.00 (Canadian dollars).   The purchase price will be paid in a
combination of shares of restricted stock, cash and a promissory note for
$500,000.   The promissory note pays no interest and will be paid in three
equal payments on January 15, 2006, February 15, 2006 and March 15, 2006.

The foregoing description of the terms and conditions of the acquisition and
promissory note are qualified in their entirety by, and made subject to, the
more complete information set forth in the Memorandum of Agreement and
Promissory Note attached to this Report as Exhibits 2.1 and 4.1, respectively.




ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS.

(a)  Financial  statements  of  businesses  acquired:

The  financial  statements  required  by this item are not included herewith and
will  be  filed  within  60  days  of the required filing date of this Form 8-K.

(b)  Pro  forma  financial  information:

The  financial  statements  required  by this item are not included herewith and
will  be  filed  within  60  days  of the required filing date of this Form 8-K.

(c)  Exhibits:

EXHIBIT NUMBER          DESCRIPTION

2.1     Memorandum of Agreement between the Company and Elaine Abate, John
        Abate, Gerhard Schmid, Frank Abate, 1066865 Ontario Inc, and Infinity
        Technologies Inc., dated July 19, 2005.

4.1     Promissory Note between the Company and Elaine Abate, John Abate, and
        Gerhard Schmid, dated July 19, 2005.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                On The Go Healthcare, Inc
Date: July 22, 2005
                                By:  /s/ Stuart Turk
                                ------------------------------------
                                Stuart Turk
                                Chief Executive Officer and President